FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law Indictment of Osteopathic Physician Signals Shift in Peptide Enforcement Stevens & Lee